Department of Clinical Sciences/Psychiatry, Umeå University, 901 87 Umeå, Sweden.
Department of Clinical Neuroscience, Karolinska Institute, 171 77 Stockholm, Sweden.
Cells. 2023 Jan 17;12(3):350. doi: 10.3390/cells12030350.
Brain-derived neurotrophic factor () has previously been associated with the pathogenesis of both emotionally unstable personality disorder (EUPD) and suicidal behavior. No study has yet investigated -associated epigenetic alterations in a group of severely impaired EUPD and suicidal patients. The discovery cohort consisted of 97 women with emotionally unstable personality disorder (EUPD) with at least two serious suicide attempts (SAs) and 32 healthy female controls. The genome-wide methylation pattern was measured by the Illumina EPIC BeadChip and analyzed by robust linear regression models to investigate mean methylation levels in a targeted analysis conditioned upon severity of suicide attempt. The validation cohort encompassed 60 female suicide attempters, stratified into low- (n = 45) and high-risk groups (n = 15) based on degree of intent-to-die and lethality of SA method, and occurrence of death-by-suicide at follow-up. Mean methylation levels exhibited increased methylation in relation to EUPD ( = 0.0159, percentage mean group difference ~3.8%). Similarly, this locus was confirmed as higher-methylated in an independent cohort of females with severe suicidal behavior ( = 0.0300). Results were independent of age and BMI. This is the first study to reveal emerging evidence of epigenetic dysregulation of with dependence on features known to confer increased risk of suicide deaths (lethality of suicide-attempt method and presence of EUPD diagnosis with history of recent SAs). Further studies investigating epigenetic and genetic effects of on severe suicidal behavior and EUPD are needed to further elucidate the role of epigenetic regulatory mechanisms and neurotrophic factors in relation to suicide and EUPD, and hold potential to result in novel treatment methods.
脑源性神经营养因子()先前与情绪不稳定型人格障碍(EUPD)和自杀行为的发病机制有关。目前尚无研究调查严重受损的 EUPD 和自杀患者群体中与相关的表观遗传改变。发现队列包括 97 名有情绪不稳定型人格障碍(EUPD)的女性,这些女性至少有两次严重的自杀企图(SA)和 32 名健康的女性对照者。通过 Illumina EPIC BeadChip 测量全基因组甲基化模式,并通过稳健的线性回归模型进行分析,以在靶向分析中调查条件下严重自杀企图的平均甲基化水平。验证队列包括 60 名女性自杀未遂者,根据自杀意图和自杀方法的致命性,将其分为低危组(n = 45)和高危组(n = 15),并在随访期间发生自杀死亡。平均 甲基化水平表现出与 EUPD 相关的甲基化增加(= 0.0159,平均组差异百分比约 3.8%)。同样,该基因座在具有严重自杀行为的女性的独立队列中也被证实为高甲基化(= 0.0300)。结果独立于年龄和 BMI。这是第一项揭示与自杀死亡风险增加(自杀企图方法的致命性和近期自杀史的 EUPD 诊断)相关的表观遗传失调的证据。需要进一步研究研究对严重自杀行为和 EUPD 的的表观遗传和遗传效应,以进一步阐明与自杀和 EUPD 相关的表观遗传调节机制和神经营养因子的作用,并有可能产生新的治疗方法。